ARTICLE | Clinical News
Vectibix panitumumab: Phase III data
August 16, 2010 7:00 AM UTC
Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: Vectibix panitumumab Business: Cancer Molecular target: Epidermal growth factor (E...